Ramy Abdelnaby: The Impact of Multiterritory Brain Infarcts on Recurrent Stroke Risk and Anticoagulation Efficacy
Ramy Abdelnaby, Consultant Neurologist / Oberarzt at RWTH Aachen University Hospital, shared on LinkedIn about a recent article by Rachel Gologorsky et al, published in Stroke Journal:
”A pivotal subgroup analysis of the ARCADIA trial, recently published in Stroke, illuminates the impact of multiterritory brain infarcts on recurrent stroke risk and the efficacy of anticoagulation in cryptogenic stroke patients.
The comprehensive study spanned from 2018 to 2022 across 185 centers, exploring atrial cardiopathy’s role in stroke recurrence and anticoagulation response.
Key findings reveal no significant association between atrial cardiopathy biomarkers, LVEF, and the number of infarct territories.
Yet, it’s the detailed examination of recurrent stroke risk and anticoagulation effects that promises to redefine clinical strategies.”
Title: Multiterritory Brain Infarcts, Anticoagulation, and Recurrence After Cryptogenic Stroke: A Subgroup Analysis of the ARCADIA Trial
Authors: Rachel Gologorsky, Maarten G. Lansberg, Max Wintermark, Christy N. Cassarly, Rebeca Aragon Garcia, Pamela Plummer, Nilushi Karunamuni, Scott E. Kasner, Babak B. Navi, Ava Liberman, Mukul Sharma, Joseph P. Broderick, W.T. Longstreth Jr., David L. Tirschwell, Richard A. Kronmal, Mitchell S.V. Elkind, Hooman Kamel
Read the Full Article on Stroke
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 31, 2026, 09:36Konstanze Aurich: Emerging Blood-Derived Products in Transfusion Medicine
-
Jul 31, 2026, 09:21Caitlin Raymond: Does Drinking More Calcium and Magnesium Every Day Raise the Calcium in My Blood?
-
Jul 31, 2026, 09:04Quentin Hill: Collaborative Progress in Immune Thrombocytopenia Drug Development
-
Jul 31, 2026, 07:54Vivek Das: From Inflammation to Integrated Precision Cardiovascular Care
-
Jul 31, 2026, 07:31Krishna Athmakuri: Evaluating Left Atrial Appendage Occlusion Against Oral Anticoagulation
-
Jul 31, 2026, 04:35Lukas Bastian Otto: Bow Hunter’s Syndrome as a Hidden Cause of Cerebellar Infarction
-
Jul 31, 2026, 04:05Shadi Tabibian: Understanding Thrombotic Risk in Rare Bleeding Disorders
-
Jul 31, 2026, 03:43American Society of Hematology Opens Doors to Hematology Education Worldwide
-
Jul 31, 2026, 03:23Roberta Gualtierotti: Major Genomic Study Identifies Novel Fibromyalgia Risk Genes